 |
 |
 |
|
| October 16, 2009 |
|
|
| August 17, 2009 |
Notice regarding Adoption and Decision of Subsidy Business related to NEDO's "Innovation Promotion Business" |
We hereby notify you that our business titled "Peritoneal Dissemination Cancer Virotherapy Using Attenuated Herpes Simplex Virus" was adopted for New Energy and Industrial Technology Development Organization's (NEDO) 2nd "Innovation Promotion Business (R&D-type venture technology development subsidy business)" of FY 2009.
|
|
| August 6, 2009 |
SA4503 has received its International Nonproprietary Name (INN) "cutamesine dihydrochloride". An INN is the official non-proprietary name given to a pharmaceutical substance, as designated by World Health Organization (WHO). |
|
| July 9, 2009 |
The Journal of Gene Medicine "Young Investigator Award" for the 14th Annual Meeting of Japan Society of Gene Therapy was presented to Dr Kasuya, Nagoya University School of Medicine, who contributed to the clinical research of HF10 performed at Nagoya University. |
|
| July 8, 2009 |
M's Science Corporation initiated a US Phase 1 study of herpes simplex virus type 1 strain HF10 in patients with Head & Neck cancer at University of Pittsburgh Medical Center and Oregon Health & Science University. |
|
| June , 2009 |
|
|
| May 28, 2008 |
|
|
| May 14, 2008 |
|
|
| March 12, 2008 |
|
|
| January 30, 2008 |
|
|
| October 12, 2007 |
|
|
| September 7, 2007 |
|
|
| August 27, 2007 |
|
|
| July 01, 2007 |
|
|
| May 23, 2007 |
|
|
|
|
